Abnormal behavior and Agranulocytosis

Summary:

Agranulocytosis is found among people with Abnormal behavior, especially for people who are male, 60+ old.

The study analyzes which people have Agranulocytosis with Abnormal behavior. It is created by eHealthMe based on reports of 61 people who have Abnormal behavior from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Abnormal behavior?

Abnormal behavior is found to be associated with 1,357 drugs and 1,957 conditions by eHealthMe. Check the latest studies of Abnormal behavior.

What is Agranulocytosis?

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 2,321 drugs and 3,597 conditions by eHealthMe. Check the latest studies of Agranulocytosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

61 people who have Abnormal Behavior and Agranulocytosis are studied.

Would you have Agranulocytosis when you have Abnormal behavior?

Gender of people who have Abnormal Behavior and experienced Agranulocytosis *:

female: 32.2 %
male: 67.8 %

Age of people who have Abnormal Behavior and experienced Agranulocytosis *:

Common co-existing conditions for these people *:

High Blood Pressure: 8 people, 13.11%
Depression: 6 people, 9.84%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 5 people, 8.20%
Aggression: 5 people, 8.20%
Agitation (state of anxiety or nervous excitement): 5 people, 8.20%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 5 people, 8.20%
Affective Disorder (mental disorder): 5 people, 8.20%
Stress And Anxiety: 5 people, 8.20%
High Blood Cholesterol: 4 people, 6.56%
Impulsive Behavior: 4 people, 6.56%

Common drugs taken by these people *:

Common symptoms for these people *:

Thrombocytopenia (decrease of platelets in blood): 13 people, 21.31%
Leukopenia (less number of white blood cells in blood): 12 people, 19.67%
Anaemia (lack of blood): 7 people, 11.48%
Fever: 7 people, 11.48%
Lymphopenia (an abnormally low level of lymphocytes in the blood): 6 people, 9.84%
White Blood Cell Count Decreased: 5 people, 8.20%
Sepsis (a severe blood infection that can lead to organ failure and death): 5 people, 8.20%
Agitation (state of anxiety or nervous excitement): 3 people, 4.92%
Lung Disorder (lung disease): 3 people, 4.92%
Pneumonia: 3 people, 4.92%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Agranulocytosis?

- Check whether Agranulocytosis is associated with a drug or a condition

Related publications that referenced our studies

Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .
Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .

Related studies:

Treatments, associated drugs and conditions:

Abnormal behavior (51,307 reports)
Agranulocytosis (213,267 reports)

All the drugs that are associated with Agranulocytosis:

Agranulocytosis (2,321 drugs)

All the conditions that are associated with Agranulocytosis:

Agranulocytosis (3,597 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Agranulocytosis and Abnormal behavior, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.